ClinicalTrials.Veeva

Menu

Validation of Ventriject Determined Maximal Oxygen Uptake

University of Copenhagen logo

University of Copenhagen

Status

Completed

Conditions

Healthy

Treatments

Other: Ventriject validation

Study type

Observational

Funder types

Other

Identifiers

NCT03504306
Ventriject1

Details and patient eligibility

About

This study aims to validate the use of the Ventriject product to estimate VO2 max, through a non-physically active test using ECG, echoseismography and echosonography.

Full description

this study will be composed of the following tests:

  • blood sample for measurement of blood values
  • blood pressure measurement to rule out risks affiliated with maximal effort testing
  • DXA body composition scanning
  • Measurement on ECG, echosonography and echoseismography with accelerometer, microphone and ECG wires
  • Measurements with phone (iPhone)
  • VO2 max assessment by maximal oxygen uptake testing on a training bike, using online oxygenmeasurement equipment
  • Hand-grip strength assessment

Enrollment

100 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy adults between 18 and 45 years of age

Exclusion criteria

  • current or previous cardiovascular disease
  • chronic use of medicine
  • pregnancy
  • illnesses which prohibits the testing of maximal oxygen uptake

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems